Add like
Add dislike
Add to saved papers

ARduino-pH Tracker (ART) and Screening Platform for Characterization of Recombinant Carbonic Anhydrase in Escherichia coli.

Carbonic anhydrase (CA, EC 4.2.1.1) is an ancient enzyme with zinc ion as its active site, which catalyzes the chemical reaction of carbon dioxide (CO2 ) to react with water and form bicarbonate ions. Due to its high catalytic efficiency on CO2 assimilation, CA is expected to use for carbon sequestration in industry. However, the protein expression level, thermostability and high throughput screening of an active CA are still with difficulty. In this study, the CA from Sulfurihydrogenibium yellowstonense (denoted as SyCA) was selected for over-expressed in E. coli by different pET vectors. The enzymatic properties including thermo-stability, pH tolerance, effect of metal ion and kinetic parameters were characterized through a novel ARduino-pH Tracker (ART) for monitoring online effectively. The SyCA is thermophilic and acidophilic as it maintains 100% activity at 50o C, while the residual activity is 34.8% after heating at 80°C for 150 min and the optimal pH is 3 to 5. The kinetic analysis by ART system showed that the kcat /Km of free enzyme was 4.4-folds that that of whole cell. On the other hand, the screening platforms as Wilbur-Anderson unit (WAU), phenol red indicator and size of colony forming unit (CFU) have been established to explore CA with higher activity. The high throughput screening platform is support in direct evolution of CA and further used in the industry. This article is protected by copyright. All rights reserved.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app